In the presence of Prime Minister Alexander De Croo, bio.be/essenscia, the Belgian sector federation for biotech and life sciences, presented its memorandum with policy proposals entitled: 'Belgian biotech for a better world'. The essential point? With the right policy choices, we can keep Belgian biotech and biopharma at the world's top.
In the heart of the BioPark in Gosselies (Charleroi) the construction of the EU Biotech Campus has begun. This state-of-the-art training centre with business accelerator – supported by essenscia – has an ambitious mission. Train more talent and support more start-ups and scale-ups to further strengthen the leading international position of the Belgian and Walloon biotech and biopharmaceutical sector, in order to welcome the next generation of biomanufacturing processes with the newest digital skills.
Since the beginning of the coronavirus crisis, the strong Belgian biotech and biopharmaceutical sector has played a key role in the global fight against this pandemic. Let’s count on this mature industry to help the country's economic recovery. Companies in the sector have already invested 5.5 billion in production facilities over the past 10 years. Let's provide the right conditions for them to further develop their biomanufacturing capabilities, becoming sustainable and digitalized industries of the future, able to find the scientific and technical talent needed for their development. These were the key messages at the annual event of the Belgian life sciences and biotechnology federation bio.be/essenscia, where one of the speakers was Thomas Dermine, Secretary of State for Recovery and Strategic Investments, responsible for Science Policy.